Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoconazole Plus GM-CSF in Progressive Prostate Cancer
NCT00309894Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Apr 2004
- Primary completion
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sargramostim in prostate cancer (PCa), sponsored by University of California, San Francisco. Primary endpoint: Time to clinical progression. Started Apr 2004; status: completed.
02
Drugs
sargramostim
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00309894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309894.